NTRA Natera, Inc. Common Stock
US$414.10
-5.02%
Latest close
Trend channel, buy level and 3-month target. Information only, not financial advice.
Below the channel · 9-month channel rising
Closed below support (US$442.42). Treat the buy level with caution.
- 9-month channel
- US$442.42 – US$491.88 · rising, more than +100% a year
- Price in channel
- −57% (0% = floor, 100% = ceiling)
- Ceiling overhead
- US$491.88
- Published levels
- Buy and target are not from this channel — see below.
Price history, with the path projected 3 months forward
Updated 5:00 PM ET (67 h ago)
- Daily close
- Upper trend line (9 months)
- Lower trend line (9 months)
- Dashed after today: projected 3 months
- Our buy
- Our target
Suggested path
Buy at or below
US$361.75
level as at 10 Nov 2026
Our target
US$470.28
by 17 Nov 2026
Projected move
30.0%
gross, before costs
Price is between our buy and target.
Target: NTRA's usual move size (30.0%), the best return per day on this path.
This move size: reached in 30% of 21 past stretches, typically in 68 days. (0.44% per day)
- Upper line touches
- 3
- Lower line touches
- 2
- Fit confidence
- 54%
- Fitted
- 1 Nov 2026
Company information
About Natera, Inc.
Natera, Inc. is a US-listed company, classified under Services-Medical Laboratories, with principal offices in AUSTIN, TX.
- Sector
- Healthcare
- Industry
- Services-Medical Laboratories
- Country
- United States
Trend lines are fitted to past swing highs and lows and may not continue. Information only, not financial advice.